156 related articles for article (PubMed ID: 2845323)
1. Complications after proton beam therapy for uveal malignant melanoma. A clinical and histopathologic study of five cases.
Kincaid MC; Folberg R; Torczynski E; Zakov ZN; Shore JW; Liu SJ; Planchard TA; Weingeist TA
Ophthalmology; 1988 Jul; 95(7):982-91. PubMed ID: 2845323
[TBL] [Abstract][Full Text] [Related]
2. The risk of enucleation after proton beam irradiation of uveal melanoma.
Egan KM; Gragoudas ES; Seddon JM; Glynn RJ; Munzenreider JE; Goitein M; Verhey L; Urie M; Koehler A
Ophthalmology; 1989 Sep; 96(9):1377-82; discussion 1382-3. PubMed ID: 2550868
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma.
Saornil MA; Fisher MR; Campbell RJ; Robertson DM; Earle JD; Eagle RC; Shields JA; Shields CL; Chandra SR; Albert DM
Arch Ophthalmol; 1997 Nov; 115(11):1395-400. PubMed ID: 9366669
[TBL] [Abstract][Full Text] [Related]
4. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
Br J Ophthalmol; 1996 Aug; 80(8):732-9. PubMed ID: 8949719
[TBL] [Abstract][Full Text] [Related]
5. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
6. Histopathology of uveal melanomas treated with charged particle radiation.
Crawford JB; Char DH
Ophthalmology; 1987 Jun; 94(6):639-43. PubMed ID: 3627712
[TBL] [Abstract][Full Text] [Related]
7. The time course of irradiation changes in proton beam-treated uveal melanomas.
Gragoudas ES; Egan KM; Saornil MA; Walsh SM; Albert DM; Seddon JM
Ophthalmology; 1993 Oct; 100(10):1555-9; discussion 1560. PubMed ID: 8414415
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
9. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
[TBL] [Abstract][Full Text] [Related]
10. Histopathology of proton beam-irradiated vs enucleated uveal melanomas.
Saornil MA; Egan KM; Gragoudas ES; Seddon JM; Walsh SM; Albert DM
Arch Ophthalmol; 1992 Aug; 110(8):1112-8. PubMed ID: 1323252
[TBL] [Abstract][Full Text] [Related]
11. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
[TBL] [Abstract][Full Text] [Related]
12. Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma.
Mashayekhi A; Tuncer S; Shields CL; Shields JA
Eur J Ophthalmol; 2013; 23(3):399-409. PubMed ID: 23483500
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study.
Avery RB; Diener-West M; Reynolds SM; Grossniklaus HE; Green WR; Albert DM
Arch Ophthalmol; 2008 Feb; 126(2):207-12. PubMed ID: 18268211
[TBL] [Abstract][Full Text] [Related]
14. Neovascular glaucoma after stereotactic radiotherapy for juxtapapillary choroidal melanoma: histopathologic and dosimetric findings.
Fernandes BF; Weisbrod D; Yücel YH; Follwell M; Krema H; Heydarian M; Xu W; Payne D; McGowan H; Simpson ER; Laperriere N; Sahgal A
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):377-84. PubMed ID: 20864264
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
16. Proton irradiation of malignant uveal melanoma. A five year follow-up of patients treated in Uppsala, Sweden.
Naeser P; Blomquist E; Montelius A; Thoumas KA
Ups J Med Sci; 1998; 103(3):203-11. PubMed ID: 10052109
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of proton beam irradiated uveal melanomas.
Gragoudas ES; Seddon JM; Egan K; Glynn R; Munzenrider J; Austin-Seymour M; Goitein M; Verhey L; Urie M; Koehler A
Ophthalmology; 1987 Apr; 94(4):349-53. PubMed ID: 3035451
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
Seibel I; Riechardt AI; Heufelder J; Cordini D; Joussen AM
Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
[TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up of helium ion therapy for uveal melanoma.
Char DH; Castro JR; Kroll SM; Irvine AR; Quivey JM; Stone RD
Arch Ophthalmol; 1990 Feb; 108(2):209-14. PubMed ID: 2302103
[TBL] [Abstract][Full Text] [Related]
20. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).
Oxenreiter MM; Lane AM; Aronow MB; Shih H; Trofimov AV; Kim IK; Gragoudas ES
Br J Ophthalmol; 2022 Apr; 106(4):518-521. PubMed ID: 33355171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
